- G Medical Innovations Holdings Ltd's (NASDAQ:GMVD) subsidiary, G Medical Tests and Services Inc, expanded its COVID-19 testing services to more than 150+ additional locations across California.
- The new testing sites include theme parks, schools, commercial properties, office complexes, public buildings, and mobile facilities.
- G Medical acquired the business conducting testing at the locations for a total of $5.2 million in cash, to be paid out in milestones.
- The new sites will enable the processing of more than 200,000 COVID-19 PCR and rapid antigen/flu tests, with anticipated revenues of $20 million.
- The company also reports it has repaid $2.5 million in cash on a $5 million convertible loan issued by Lind Partners.
- The need for convenient COVID-19 PCR, Rapid Antigen/Flu testing, personal healthcare monitoring continues along with the company's Prizma Care remote patient monitoring directly to consumers.
- Price Action: GMVD shares are up 7.64% at $2.96 during the market session on the last check Tuesday.
Get all your news in one place.
100’s of premium titles.
One app.
Start reading
One app.
Get all your news in one place.
100’s of premium titles. One news app.
G Medical Innovations' Subsidiary Expands COVID-19 Testing To Additional Locations In California
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member?
Sign in here
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member?
Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member?
Sign in here
Our Picks